SeraphLuke (Talk | contribs) |
SeraphLuke (Talk | contribs) |
||
Line 134: | Line 134: | ||
<tr> | <tr> | ||
<td><p>iGEM projects involve important questions beyond the lab bench, for example relating to (but not limited to) ethics, sustainability, social justice, safety, security, and intellectual property rights. Demonstrate how your team has identified, investigated, and addressed one or more of these issues in the context of your project. Your activity could center around education, public engagement, public policy issues, public perception, or other activities (see the human practices hub for more information and examples of previous teams' exemplary work).</p></td> | <td><p>iGEM projects involve important questions beyond the lab bench, for example relating to (but not limited to) ethics, sustainability, social justice, safety, security, and intellectual property rights. Demonstrate how your team has identified, investigated, and addressed one or more of these issues in the context of your project. Your activity could center around education, public engagement, public policy issues, public perception, or other activities (see the human practices hub for more information and examples of previous teams' exemplary work).</p></td> | ||
− | <td><p>We collaborated with | + | <td><p>We collaborated with the Rice Institute of Biosciences and Bioengineering (IBB) to host a bioethics debate on synthetic biology with young women from a local, underserved high school. At the Houston Children’s Museum, we helped host a Building with Biology public education event. Taking note of the proximity of the Texas Medical Center to Rice, we reached out to physicians for insight regarding current colonoscopy methods. Finally, we made social media posts (Humans of SynBio), featuring passionate members of iGEM teams from around the world, with a goal to inspire the public and correct any misconceptions between the SynBio community and the general public.</p></td> |
</tr> | </tr> | ||
</table> | </table> | ||
Line 157: | Line 157: | ||
<tr> | <tr> | ||
<td><p>Improve the function OR characterization of an existing BioBrick Part or Device and enter this information in the Registry. Please see the Registry help page on how to document a contribution to an existing part. This part must NOT be from your 2016 part number range.</p></td> | <td><p>Improve the function OR characterization of an existing BioBrick Part or Device and enter this information in the Registry. Please see the Registry help page on how to document a contribution to an existing part. This part must NOT be from your 2016 part number range.</p></td> | ||
− | <td><p> | + | <td><p>We discovered that NarK’s characterization deviated from results featured in previous iGEM Wikis.</p></td> |
</tr> | </tr> | ||
</table> | </table> |
Revision as of 07:46, 19 October 2016